BIONDO FOCUS FUND | |||||||
SCHEDULE OF INVESTMENTS (Unaudited) | |||||||
September 30, 2021 | |||||||
Shares | Fair Value | ||||||
COMMON STOCKS — 97.3% | |||||||
BANKING - 4.4% | |||||||
5,375 | SVB Financial Group(a) | $ 3,476,980 | |||||
BIOTECH & PHARMA - 9.1% | |||||||
90,000 | BioCryst Pharmaceuticals, Inc.(a) | 1,293,300 | |||||
55,000 | Iovance Biotherapeutics, Inc.(a) | 1,356,300 | |||||
5,000 | Moderna, Inc.(a) | 1,924,300 | |||||
25,000 | Reata Pharmaceuticals, Inc., Class A(a) | 2,515,250 | |||||
7,089,150 | |||||||
E-COMMERCE DISCRETIONARY - 4.2% | |||||||
1,000 | Amazon.com, Inc.(a) | 3,285,040 | |||||
HEALTH CARE FACILITIES & SERVICES - 1.1% | |||||||
6,500 | Teladoc Health, Inc.(a) | 824,265 | |||||
INTERNET MEDIA & SERVICES - 4.3% | |||||||
1,250 | Alphabet, Inc., Class A(a) | 3,341,900 | |||||
MEDICAL EQUIPMENT & DEVICES - 31.6% | |||||||
20,000 | ABIOMED, Inc.(a) | 6,510,400 | |||||
30,000 | Edwards Lifesciences Corporation(a) | 3,396,300 | |||||
20,000 | Exact Sciences Corporation(a) | 1,909,000 | |||||
10,000 | Illumina, Inc.(a) | 4,056,100 | |||||
7,500 | Intuitive Surgical, Inc.(a) | 7,456,125 | |||||
7,000 | Shockwave Medical, Inc.(a) | 1,441,160 | |||||
24,769,085 | |||||||
RETAIL - DISCRETIONARY - 4.4% | |||||||
200,000 | Bed Bath & Beyond, Inc.(a) | 3,455,000 | |||||
SEMICONDUCTORS - 2.1% | |||||||
8,000 | NVIDIA Corporation | 1,657,280 | |||||
SOFTWARE - 11.2% | |||||||
6,500 | Adobe, Inc.(a) | 3,742,180 | |||||
9,500 | Atlassian Corp plc, Class A(a) | 3,718,490 |
BIONDO FOCUS FUND | |||||||
SCHEDULE OF INVESTMENTS (Unaudited) (Continued) | |||||||
September 30, 2021 | |||||||
Shares | Fair Value | ||||||
COMMON STOCKS — 97.3% (Continued) | |||||||
SOFTWARE - 11.2% (Continued) | |||||||
1,000 | Shopify, Inc., Class A(a) | $ 1,355,780 | |||||
8,816,450 | |||||||
TECHNOLOGY HARDWARE - 9.8% | |||||||
54,000 | Apple, Inc. | 7,641,000 | |||||
TECHNOLOGY SERVICES - 15.1% | |||||||
15,000 | Mastercard, Inc., Class A | 5,215,200 | |||||
27,500 | Square, Inc., Class A(a) | 6,595,600 | |||||
11,810,800 | |||||||
TOTAL COMMON STOCKS (Cost $34,015,562) | 76,166,950 | ||||||
SHORT-TERM INVESTMENTS — 0.2% | |||||||
MONEY MARKET FUNDS - 0.2% | |||||||
167,588 | First American Treasury Obligations Fund, Class X, 0.01% (Cost $167,588)(b) | 167,588 | |||||
Contracts(c) | |||||||
EQUITY OPTIONS PURCHASED - 1.2% | Broker/Counterparty | Expiration Date | Exercise Price | Notional Value | |||
CALL OPTIONS PURCHASED (a) - 1.2% | |||||||
40 | ABIOMED, Inc. | Cowen & Co. | 01/24/2022 | $ 150 | $ 600,000 | 713,400 | |
20 | Boeing Company | Cowen & Co. | 01/24/2022 | 110 | 220,000 | 220,950 | |
TOTAL CALL OPTIONS PURCHASED (Cost - $286,952) | 934,350 | ||||||
TOTAL EQUITY OPTIONS PURCHASED (Cost - $286,952) | 934,350 | ||||||
TOTAL INVESTMENTS - 98.7% (Cost $34,470,102) | $ 77,268,888 | ||||||
OTHER ASSETS IN EXCESS OF LIABILITIES- 1.3% | 1,055,712 | ||||||
NET ASSETS - 100.0% | $ 78,324,600 | ||||||
PLC | - Public Limited Company |
(a) | Non-income producing security. |
(b) | Rate disclosed is the seven day effective yield as of September 30, 2021. |
(c) | Each option contract allows the holder of the option to purchase or sell 100 shares of the underlying security. |